Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
Bristol-Myers Squibb Company
Provisional
New Brunswick, NJ · united states
1 recall flag(s)
FDA Flags (1)
Class II Recall
Oct 2025
Bristol-Myers Squibb Company
Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only,
Classification: Class II
Bristol-Myers Squibb Company | MedicineWatch US